Language selection

Search

Details for: SEROQUEL

Company: ASTRAZENECA CANADA INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02236951SEROQUELQUETIAPINE (QUETIAPINE FUMARATE)25 MGTABLETORAL
02236952SEROQUELQUETIAPINE (QUETIAPINE FUMARATE)100 MGTABLETORAL
02236953SEROQUELQUETIAPINE (QUETIAPINE FUMARATE)200 MGTABLETORAL
02244107SEROQUELQUETIAPINE (QUETIAPINE FUMARATE)300 MGTABLETORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
Summary Safety Review - Atypical Antipsychotics - Liver failure
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of sleep walking and sleep-related eating disorder
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: